Added value of HER-2 amplification testing by multiplex ligation-dependent probe amplification in invasive breast cancer.

Added value of HER-2 amplification testing by multiplex ligation-dependent probe amplification in invasive breast cancer.

<h4>Background</h4>HER-2 is a prognostic and predictive marker, but as yet no technique is perfectly able to identify patients likely to benefit from HER-2 targeted therapies. We aimed to prospectively assess the added value of first-line co-testing by IHC, and multiplex ligation-depende...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chantal C H J Kuijpers, Cathy B Moelans, Henk-Jan van Slooten, Anja Horstman, John W J Hinrichs, Shaimaa Al-Janabi, Paul J van Diest, Mehdi Jiwa
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/1f6119dbaea041c9aea6bb77eb8da9b5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares